Aclaris Therapeutics Newsroom

Express News | Aclaris Therapeutics Inc -Files Prospectus for Offer, Resale by Selling Stockholders of up to 35.6 Mln Shares of Common Stock

BreakingsDec 20 05:34

Jefferies Maintains Aclaris Therapeutics(ACRS.US) With Buy Rating, Maintains Target Price $7

Futu NewsDec 18 23:33 · Ratings

Aclaris Therapeutics: Promising Pipeline and Strong Financial Outlook Drive Buy Rating

TipRanksDec 18 22:35 · Ratings

Stifel Maintains Aclaris Therapeutics(ACRS.US) With Hold Rating, Raises Target Price to $5

Futu NewsDec 17 10:32 · Ratings

Stifel Nicolaus Remains a Hold on Aclaris Therapeutics (ACRS)

TipRanksDec 17 10:05 · Ratings

Sino biopharm (01177.HK) has reached a global cooperation agreement with博奥信 and aclaris therapeutics.

On December 5th, Gelonghui reported that sino biopharm (01177.HK) announced that the group has reached a global cooperation agreement with Aclaris Therapeutics, Inc. concerning their jointly developed TSLP monoclonal antibody "BSI-045B (TQC2731)" with Boaoxin Biotechnology (Nanjing) Co., Ltd. ("Boaoxin").

Gelonghui FinanceDec 5 16:32

Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswireDec 4 05:30

Express News | Aclaris Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

BreakingsDec 4 05:30

Aclaris Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference

GlobeNewswireNov 27 05:30

Aclaris Therapeutics And 2 Other US Penny Stocks To Watch

Yahoo FinanceNov 22 08:04

Aclaris Upgraded to Overweight by Cantor on In-licensing Deal

Seeking AlphaNov 21 05:55

Cantor Fitzgerald Upgrades Aclaris Therapeutics(ACRS.US) to Buy Rating

Futu NewsNov 21 05:32 · Ratings

Aclaris Therapeutics Upgraded to Buy From Hold at Jefferies

Yahoo FinanceNov 20 18:11

Aclaris Therapeutics Upgraded to Buy From Neutral at BTIG

Yahoo FinanceNov 20 10:30

This Healthcare Stock Is Soaring Following Exclusive License Agreement Announcement

YolowireNov 20 05:26

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

BenzingaNov 20 05:05

Aclaris Stock Soars As Analysts See Fresh Momentum After Strategic Review And Encouraging Promising Pipeline Developments

BenzingaNov 20 04:27

Aclaris Therapeutics Up 53%; Analysts' Target Boosts Follow Monday License News

WSJNov 20 03:21

Top Midday Gainers

MT NewswiresNov 20 03:19

Trending Stocks Today | Volato Group Soars 108.72%

November 19th - US stocks trending in regular trading hours.Gainers: $Volato Group(SOAR.US)$ surges 108.72% to $0.44 with a turnover of $359.78 million. $PainReform(PRFX.US)$ shoots up 145.79% to $1.3

Futu NewsNov 20 02:15